Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.56
-1.00 (-7.37%)
At close: Feb 27, 2026, 4:00 PM EST
13.00
+0.44 (3.50%)
After-hours: Feb 27, 2026, 5:36 PM EST
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 427 employees as of December 31, 2024. The number of employees decreased by 25 or -5.53% compared to the previous year.
Employees
427
Change (1Y)
-25
Growth (1Y)
-5.53%
Revenue / Employee
$410,094
Profits / Employee
-$518,143
Market Cap
989.71M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | 55 | 30 | 120.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,500 |
| Valneva SE | 700 |
| AbCellera Biologics | 596 |
| MannKind | 407 |
| Xeris Biopharma Holdings | 394 |
| UroGen Pharma | 287 |
| uniQure | 209 |
| Cullinan Therapeutics | 111 |
PHAT News
- 3 days ago - Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance - GlobeNewsWire
- 6 days ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 12 days ago - Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026 - GlobeNewsWire
- 24 days ago - Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026 - GlobeNewsWire
- 7 weeks ago - Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 7 weeks ago - Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 7 weeks ago - Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire